- Vivid or disrupted dreams are reported anecdotally by some apigenin users; no trial in the evidence measured dreams
- Drowsiness is a possible effect at the common 50mg dose, but no trial of pure apigenin has measured sedation, and the one 50 mg evening blend trial did not produce significant improvements [1]
- Some users say apigenin seemed to worsen their sleep; in a chamomile extract pilot in adults with chronic insomnia there was no significant effect on any sleep measure, so benefit and harm are both unproven [2]
- Because apigenin has been studied at GABA receptors, combining it with sedating medications is worth discussing with a clinician, but the interaction is theoretical and no clinical apigenin interaction study is in the evidence [3][4]
Apigenin, the chamomile-derived compound marketed for sleep and relaxation, has a mostly favorable safety reputation. But the negative-review pattern is consistent enough across sources to be worth documenting plainly, especially since some of it runs counter to what the marketing promises.
Vivid Dreams and Disrupted Sleep
Despite being sold as a sleep aid, some users mention more intense or vivid dreaming or disrupted sleep. These are vendor blog reports, not trial findings. No verified trial measured dream intensity, and apigenin’s GABA-receptor action is unsettled (in cell work it inhibited GABA activation on its own), so the cause of any dream changes is unknown [3].
Oversedation at Standard Doses
Apigenin has been studied at GABA receptors, but in mice it was anxiolytic without sedation or muscle relaxation at doses like those used for classic benzodiazepines, and rats given injected apigenin moved less without showing anxiolysis, so sedation in people is not established. The common supplement dose is 50 mg, and the 50 mg evening blend trial in healthy adults did not produce significant improvements [5][6][1]. Some users report drowsiness and mild dizziness. The NIH lists dizziness and nausea as uncommon chamomile side effects, but no apigenin trial shows that a lower dose or a light snack helps [7].
Research note: In the chamomile extract insomnia pilot, adverse events were mild and transient, and the authors reported no significant differences in adverse events between the chamomile and placebo groups [11].
The Ironic Complaint: Insomnia
Some users say apigenin seemed to worsen rather than improve their sleep. This rests on user reports; in a 28-day chamomile extract pilot in 34 adults with chronic primary insomnia there was no significant effect on any sleep measure, so individual response should be watched rather than assumed uniform [2].
Allergic Reactions in Chamomile-Sensitive Users
Allergy is documented for chamomile: allergenic proteins in chamomile extract can cause immediate-type reactions, including in people allergic to other daisy-family plants, and the EU monograph lists severe reactions including anaphylactic shock. Whether purified apigenin causes the same reactions is not shown [8][9].
Medication Interaction Warnings
Combining apigenin with sedating or psychiatric medications is a theoretical concern: reviews flag chamomile with opioids and other central nervous system depressants, but note that most herb-drug interaction information comes from case reports, animal studies and in vitro data. Anyone on prescription psychiatric medication should talk to a doctor before adding apigenin to a stack [4].
Digestive Discomfort
Some users mention digestive discomfort. In chamomile trials the most common adverse events were gastrointestinal upset and drowsiness, both self-limiting, but those trials used chamomile and not pure apigenin [10].
FAQ
Why does apigenin cause vivid dreams?
No verified trial measured dreams, and apigenin’s GABA-receptor action is unsettled, so the cause of reported vivid dreams is unknown [3].
Can apigenin make sleep worse instead of better?
Some users say so, but this rests on user reports and not on trials, and trial evidence in chronic insomnia was null, so watch your own response [2].
Is 50mg apigenin a lot?
It is a common label dose, and no trial of pure apigenin shows that sedation or drowsiness is commonly reported at it [1].
References
- Mastrofini GF et al. Modulating stress and sleep through a multi-compound dietary supplement: a randomized, double-blind, placebo-controlled trial. Journal of the International Society of Sports Nutrition (2026). PMID 42829807
- Atena Pasban et al. The Effect of Chamomile on Common Psychological Disorders Including Depression, Anxiety, Stress and Sleep Disorders: A Narrative Review. Iranian Journal of Psychiatry and Behavioral Sciences (2025). doi:10.5812/ijpbs-157547
- Campbell EL et al. The dietary flavonoids apigenin and (-)-epigallocatechin gallate enhance the positive modulation by diazepam of the activation by GABA of recombinant GABA(A) receptors. Biochemical pharmacology (2004). PMID 15451406
- Abebe W Herbal medication: potential for adverse interactions with analgesic drugs. Journal of clinical pharmacy and therapeutics (2002). PMID 12472978
- Haydée Viola et al. Apigenin, a Component ofMatricaria recutitaFlowers, is a Central Benzodiazepine Receptors-Ligand with Anxiolytic Effects. Planta Medica (1995). PMID 7617761
- Zanoli P et al. Behavioral characterisation of the flavonoids apigenin and chrysin. Fitoterapia (2000). PMID 10930722
- National Center for Complementary and Integrative Health (NIH) Chamomile: Usefulness and Safety. National Center for Complementary and Integrative Health (NIH) source
- Sogand Saadatmand et al. The Effect of Oral Chamomile on Anxiety: A Systematic Review of Clinical Trials. Clinical Nutrition Research (2024). PMID 38784853
- European Medicines Agency (HMPC) European Union herbal monograph on Matricaria recutita L., flos (EMA/HMPC/55843/2011). European Medicines Agency (HMPC) (2015). source
- Ostovar M et al. Chamomile: A systematic review of adverse events. Complementary therapies in medicine (2025). PMID 40374153
- Zick SM et al. Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary insomnia: a randomized placebo-controlled pilot study. BMC complementary and alternative medicine (2011). PMID 21939549
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
